Rua Bioscience Limited (RUA.NZ)
NZD 0.03
(0.0%)
NZD 0.03
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 | -4.84 Million NZD | 62.77% |
| 2023 | -13 Million NZD | -73.66% |
| 2022 | -7.48 Million NZD | -13.03% |
| 2021 | -6.62 Million NZD | -52.54% |
| 2020 | -4.34 Million NZD | -92.34% |
| 2019 | -2.25 Million NZD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 FY | -4.84 Million NZD | 62.77% |
| 2024 Q2 | -2.44 Million NZD | -110.54% |
| 2024 Q4 | 1.15 Million NZD | 0.0% |
| 2024 Q1 | -1.16 Million NZD | 86.58% |
| 2023 FY | -13 Million NZD | -73.66% |
| 2023 Q2 | -3.65 Million NZD | -109.62% |
| 2023 Q4 | -8.64 Million NZD | -102.85% |
| 2023 Q1 | -1.74 Million NZD | 59.73% |
| 2023 Q3 | -4.26 Million NZD | -16.68% |
| 2022 Q1 | -1.76 Million NZD | 44.37% |
| 2022 FY | -7.48 Million NZD | -13.03% |
| 2022 Q4 | -4.32 Million NZD | -112.9% |
| 2022 Q3 | -2.03 Million NZD | 47.62% |
| 2022 Q2 | -3.87 Million NZD | -120.38% |
| 2021 FY | -6.62 Million NZD | -52.54% |
| 2021 Q4 | -3.16 Million NZD | -125.47% |
| 2021 Q3 | -1.4 Million NZD | 59.62% |
| 2021 Q2 | -3.47 Million NZD | -100.0% |
| 2021 Q1 | -1.73 Million NZD | 28.09% |
| 2020 FY | -4.34 Million NZD | -92.34% |
| 2020 Q2 | -2.04 Million NZD | -100.0% |
| 2020 Q4 | -2.41 Million NZD | -110.53% |
| 2020 Q1 | -1.02 Million NZD | 0.0% |
| 2020 Q3 | -1.14 Million NZD | 43.96% |
| 2019 FY | -2.25 Million NZD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| AFT Pharmaceuticals Limited | 24.23 Million NZD | 119.972% |
| Greenfern Industries Limited | -1.45 Million NZD | -233.266% |